A clear pattern called the central vein sign (seen on certain MRI scans) can help doctors tell multiple sclerosis (MS) apart from other conditions with high accuracy.
Researchers looked at 28 studies with 3,434 people to see how well the central vein sign (CVS) works for diagnosing MS. The CVS is when a small vein appears in the middle of an MRI lesion — think of a tiny thread running through a spot on a photo. One rule that checks the percentage of lesions with a central vein worked best when about 37.5% of a person’s lesions had the vein; this correctly identified MS in most people (high sensitivity) and correctly ruled it out in most others (high specificity). Another simpler rule that counts 4 lesions with a central vein on a specific MRI type also worked well, though a bit less accurate than the percentage rule. Using a contrast dye (gadolinium) during MRI scans did not meaningfully change how well the CVS rules worked.
People living with MS and their caregivers should care because this imaging sign can help doctors make a clearer diagnosis — like finding a unique fingerprint in brain scans that points to MS. Neurologists and MRI technicians benefit because CVS gives another objective tool to tell MS from other causes of brain spots. If your doctor uses the percentage rule (about 37.5% of lesions with a vein), it may give more confidence in diagnosis and guide treatment choices sooner. For everyday life, a clearer diagnosis can mean faster access to MS treatments, fewer unnecessary tests, and less uncertainty for you and your family. Care teams can use CVS results alongside symptoms and other tests, much like using several clues together to solve a puzzle.
Most studies were done in specialized centers with experienced reviewers, so results might be less strong in places with less MRI expertise or different scanners. The tests work best with certain MRI sequences (ways of taking the pictures), so not every hospital’s MRI setup will give the same clarity — think of it like needing a higher-quality camera to see a small detail. Also, while the CVS rules are helpful, they are not perfect; doctors will still consider symptoms, other tests, and follow-up before making a final diagnosis.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.